James E. Levine - 19 Jun 2026 Form 4 Insider Report for KAZIA THERAPEUTICS LTD (KZIA)

Reporting relationship: Chief Financial Officer
Issuer ticker: KZIA
Reported as of: 19 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Jun 2026, 18:47:31 UTC
Prior SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ James Levine

Key filing fact

James E. Levine filed Form 4 for KAZIA THERAPEUTICS LTD (KZIA) on 23 Jun 2026.

Key facts

This page summarizes James E. Levine's Form 4 filing for KAZIA THERAPEUTICS LTD (KZIA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 23 Jun 2026, 18:47.

Change

Previous filing in this sequence was filed on 15 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001463151 Primary reporting owner

Levine James E.

Relationship: Chief Financial Officer
Address: THREE INTERNATIONAL TOWERS, LEVEL 24, 300 BARANGAROO AVENUE, SYDNEY, AUSTRALIA
Signature: /s/ James Levine
Signature date: 23 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KZIA transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +200,000
Change %
Price: $0.000000^*
Shares after: 200,000
Date: 19 Jun 2026
Ownership: Direct
Underlying class: ADSs
Underlying amount: 200,000
Exercise price: $13.86
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of 200,000 options over ADSs on June 19, 2026, at an exercise price of $13.86 per ADS. One-third of the options vest on June 1, 2026 (the "Commencement Date") and the remaining two-thirds vest in equal yearly tranches on the anniversary of the Commencement Date. All options held by the Reporting Person will be forfeited upon the Reporting Person's voluntary departure prior to the first anniversary of the Commencement Date. The options were granted for no consideration and expire on June 19, 2029.